Mark Schweitzer
is global director of global analytical R&D at Abbott Laboratories in Abbott park, IL, and a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Analytical Technical Group (ATG).
Articles
Implications and Opportunities of Applying QbD Principles to Analytical Measurement
Kevin Smith (Cephalon);Matthias Pohl;Mark Schweitzer;Jaqueline Larew;Melissa Hanna-Brown;Gordon Hansen;Phil Nethercote;Phil Borman
February 1st 2010The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 21st 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 21st 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 21st 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 21st 2024
Exploring Opportunities for LNP Delivery in mRNA
